Text Marked By [* * *] Has Been Omitted Pursuant To A Request For Confidential Treatment And Was Filed Separately With The Securities And Exchange Commission. UNIVERSITY of PENNSYLVANIA Patent License AgreementPatent License Agreement • March 21st, 2012 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • Pennsylvania
This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and ImmunoCellular Therapeutics, Ltd., a corporation organized and existing under the laws of Delaware (“Company”). This Agreement is being signed on February 10, 2012 (the “Execution Date”). This Agreement will become effective on February 10, 2012 (the “Effective Date”).
Text Marked By [* * *] Has Been Omitted Pursuant To A Request For Confidential Treatment And Was Filed Separately With The Securities And Exchange Commission. EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS HOPKINS UNIVERSITY IMMUNOCELLULAR...Exclusive License Agreement • March 21st, 2012 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • Maryland
THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is entered into by and between THE JOHNS HOPKINS UNIVERSITY, a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218-2695 (“JHU”) and IMMUNOCELLULAR THERAPEUTICS, LTD., a Delaware corporation having an address at 21900 Burbank Blvd, 3rd Floor, Woodland Hills, CA 91367 (“Company”), with respect to the following:
